This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Columbia University, University of Kentucky Research Foundation, University of Michigan. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2012-2015
Title: Innovations of Mei-Chuan Holden Ko
Introduction
Mei-Chuan Holden Ko is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of anti-cocaine therapeutics, holding 2 patents that focus on innovative treatments for cocaine-induced conditions. His work is characterized by a commitment to developing effective solutions for serious health issues.
Latest Patents
One of his latest patents involves anti-cocaine compositions and treatment. The embodiments of this invention relate to highly efficient, thermostable, and long-lasting cocaine esterase (CocE) mutants. These mutants are designed to protect against the toxic and reinforcing effects of cocaine in subjects. The patent provides mutant CocE polypeptides that display thermostable esterase activity. Additionally, it outlines methods for treating cocaine-induced conditions in subjects through the administration of mutant CocE, as well as methods for high-throughput screening of candidate esterase polypeptides.
Career Highlights
Throughout his career, Mei-Chuan Holden Ko has worked with prestigious institutions such as Columbia University and the University of Michigan. His research has significantly advanced the understanding and treatment of cocaine addiction, showcasing his dedication to public health and innovation.
Collaborations
Some of his notable coworkers include Donald W. Landry and Joanne MacDonald, who have contributed to his research endeavors and collaborative projects.
Conclusion
Mei-Chuan Holden Ko's work in developing anti-cocaine therapeutics highlights his innovative spirit and commitment to addressing critical health challenges. His contributions continue to pave the way for advancements in treatment options for cocaine-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile